Andere talen IPH Limited

Aandelen

Beurs gesloten - Australian S.E. Andere beurzen 08:10:45 19-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
6,1 ^AUD	-1,13%		-1,77%	-4,84%

29/02	IPH Limited kondigt wijzigingen in de leiding aan	CI
28/02	IPH-directeur doet afstand van aandelen in bedrijf	MT

IPH Limited Announces Executive Changes	29/02
IPH Managing Director Pares Shareholding in Firm	28/02
IPH Reports H1 FY24 Revenue Up 22%, EPS of AU$0.0879	21/02
IPH Ltd. Reports H1 FY24 Revenue Up 21% to AU$274.4 Million; Underlying Diluted EPS of AU$0.212	21/02
IPH Limited Reports Earnings Results for the Half Year Ended December 31, 2023	21/02
US FDA Ends Partial Clinical Hold on Innate Pharma's Investigational Cancer Drug	04/01
Sanofi Licenses Natural Killer Cell Engager Program from Innate Pharma	19/12
IPH Completes ROBIC Business Acquisition	18/12
IPH Limited completed the acquisition of ROBIC L.L.P.	15/12
IPH Announces Third Canadian Acquisition with AU$124 Million Deal	22/11
IPH Managing Director and CEO Sells Company Shares	22/11
IPH Limited entered into an agreement to acquire ROBIC L.L.P. for CAD 110 million.	20/11
IPH Limited Approves Election of Director, David Wiadrowski	15/11
IPH Limited Seeks Acquisitions	15/11
IPH Completes AU$75 Million Acquisition of Canadian IP Services Firm	02-10-23
Australia Inc roiled by string of cyber attacks since late 2022	29-09-23
IPH's Net Profit Jumps 23% in Fiscal Year 2023; Shares Rally 10%	17-08-23
IPH Limited Seeks Acquisitions	17-08-23
IPH Limited Reports Earnings Results for the Full Year Ended June 30, 2023	17-08-23
IPH Limited Declares Final Dividend for the Fiscal Year 2023, Payable on 15 September 2023	17-08-23

Geen resultaten voor deze zoekopdracht